Comparative analysis of metabolic risk factors for progression of non-alcoholic fatty liver disease

التفاصيل البيبلوغرافية
العنوان: Comparative analysis of metabolic risk factors for progression of non-alcoholic fatty liver disease
المؤلفون: Aivi A. Rahman, Michael Sun, Vincent J. H. Yao, J. C. W. Chan, Elizabeth Zheng, Zachariah Samuel, Alan C. Yao
المصدر: Clinical and Experimental Hepatology
بيانات النشر: Termedia Publishing House, 2021.
سنة النشر: 2021
مصطلحات موضوعية: medicine.medical_specialty, Original Paper, Hepatology, business.industry, Fatty liver, fibrosis, nutritional and metabolic diseases, medicine.disease, Gastroenterology, Obesity, transient elastography, risk factor, Internal medicine, NAFLD, medicine, Risk factor, Steatosis, Steatohepatitis, Transient elastography, business, skin and connective tissue diseases, liver stiffness measurement, Body mass index, Dyslipidemia
الوصف: Aim of the study Non-alcoholic fatty liver disease (NAFLD), a globally prevailing chronic liver condition, refers to a spectrum of disease ranging from bland steatosis to steatohepatitis causing fibrosis without significant alcohol intake. Prominent risk factors (RFs) include obesity, type 2 diabetes mellitus, and dyslipidemia. Currently, no established hierarchy exists for the influence of metabolic RFs on NAFLD progression. This retrospective cohort study investigated and ranked the independent and combined effects of three major RFs on NAFLD progression. Material and methods 652 NAFLD patients with ≥ 1 RF were categorized by RF combination to examine yearly changes in RF severity with liver stiffness measurement (LSM) over five years. Body mass index (BMI), hemoglo- bin A1c (HbA1c), total cholesterol (TC), and LSM were reviewed. Results In patients with any single improving RF, decreases in BMI were associated with a yearly LSM change of -1.26 kPa, while decreases in HbA1c and TC were associated with a change of -0.51 kPa and -0.56 kPa, respectively. In patients with any single worsening RF, increases in BMI were correlated with an LSM change of +0.74 kPa and increases in HbA1c and TC were correlated with a change of +0.43 kPa and +0.16 kPa, respectively. Patients with three RFs had the greatest LSM changes for both improving (-3.68 kPa) and worsening (+3.19 kPa) groups. The strongest predictors for LSM change were BMI and HbA1c, with standardized β coefficients of 0.236 and 0.226 (p < 0.001), while TC had the least influence [0.112 (p < 0.01), F(3,647) = 11.458, p < 0.001, R2 = 0.155]. Conclusions Obesity was the most prominent RF. Treatment of all three RFs over a five-year period presented a high likelihood of fibrosis stage regression for NAFLD patients.
اللغة: English
تدمد: 2449-8238
2392-1099
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ea843a2e41b70d92de5e7500408484f
http://europepmc.org/articles/PMC8284171
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....3ea843a2e41b70d92de5e7500408484f
قاعدة البيانات: OpenAIRE